CIK 0002035832
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Aktis Oncology, Inc.
Sign in to watch- Ticker
- AKTS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 852584233
- Phone
- +1 978-237-4380
- Business address
- 17 DRYDOCK AVENUE, SUITE #17-401, BOSTON, MA, 02210
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13D Stake Beneficial Ownership Report
Page 1 of 1 · 6 filings